I’m surprised there are few articles in the news about how they work, and why it’s a big deal. One of the other vaccines developed in China uses a common adenovirus as a carrier for the SARS-COV-2 genetic material and that was why it had lower efficacy. The Oxford vaccine uses some less-common adenovirus, which is somewhat better, but mRNA lets you bypass using viruses as a vector altogether.
You're right, but what matters much more is that the investors realized the potential (5x in 1 year after the correction). Moderna was on the roadmap for ARK invest for a long time (and compensated for it heavily).
Now that mRNA is proven technology, it can bring all other gene technologies up with it.
